Lim, Ka Keat <br/><br/>
Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.  [electronic resource] 

 -  Applied health economics and health policy  06 2018 
 - 395-406 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1179-1896 
<br/><br/><label>Standard No.: </label>10.1007/s40258-018-0384-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--diagnosis<br/>Cost-Benefit Analysis<br/>Developed Countries<br/>Early Detection of Cancer<br/>Female<br/>Genes, BRCA1<br/>Genetic Testing--economics<br/>Humans<br/>Likelihood Functions<br/>Markov Chains<br/>Mutation--genetics<br/>Quality-Adjusted Life Years<br/>Sensitivity and Specificity